Quantum companies win their first enterprise customers in two places. R&D groups in pharma, chemicals, finance and logistics pay for scoped exploration studies. Security teams buy post-quantum cryptography work because NIST published its first standards in August 2024. Sell one paid, time-boxed project to a named owner, and use cloud marketplaces and government programmes to get through the door.
Which enterprise teams buy quantum today?
R&D and innovation groups in pharmaceuticals, chemicals and financial services buy first. McKinsey's 2026 Quantum Technology Monitor counts more than 300 companies actively engaging with quantum computing and puts early value in those three industries. It reports that quantum computing companies earned more than $1 billion in revenue in 2025, and that one third of the companies it studied spend more than $10 million a year on quantum. Logistics and manufacturing teams buy optimisation studies for routing and scheduling.
These buyers fund a business problem with a number attached: the binding energy of a drug candidate, the stability of a catalyst, the run time of a risk simulation, the cost of a delivery schedule. Lead with the problem and the metric, put the hardware and the qubit count in the appendix.
Why do security teams buy post-quantum products now?
Security teams have standards and deadlines. On 13 August 2024, NIST approved FIPS 203, 204 and 205, the first standards for post-quantum key establishment and digital signatures, and told administrators to start integrating them immediately. The dates that followed give a CISO a reason to buy this year:
- NIST's draft transition plan, IR 8547 (November 2024, still a draft), deprecates quantum-vulnerable algorithms at 112 bits of security strength after 2030 and disallows all quantum-vulnerable public-key algorithms after 2035.
- The UK NCSC (March 2025) asks large organisations and critical infrastructure operators to finish discovery and an initial migration plan by 2028, complete priority migrations by 2031, and complete migration by 2035.
- The EU roadmap (June 2025) asks Member States to start the transition by the end of 2026 and critical infrastructure to finish by the end of 2030.
Every timeline starts with discovery, so the first post-quantum purchase is usually a cryptographic inventory. Target banks, telecoms, government suppliers and critical infrastructure operators first, because the NCSC and EU dates name them directly.
Should the first deal be a paid exploration or a production contract?
For quantum computing, sell a paid exploration and write the path to production into the first contract. Hardware has not reached utility scale yet. DARPA's Quantum Benchmarking Initiative is still testing whether any approach can deliver an industrially useful quantum computer by 2033, and enterprise R&D heads read the same news. They will fund a study with a clear benchmark. Few will sign a production contract for computing.
Scope the study so it can lead to a second purchase:
- Agree one problem, one dataset and one success metric with the sponsor.
- Run a classical baseline next to the quantum or quantum-inspired method, so the result stands on its own.
- Charge a fixed fee. Free work has no budget owner, and a project without a budget owner rarely gets a second phase.
- Name the decision the sponsor will make at the end, and the budget it will come from.
- Book the readout meeting with the sponsor's manager on the day you sign.
Post-quantum security firms can sell production from the first deal. Libraries, key management, certificate tooling and inventory software run today, so an annual licence or subscription after a short discovery project is a normal first shape.
Do AWS Braket and Azure Quantum help you sell?
They remove procurement and billing friction, and the demand still has to come from your own outreach. Amazon Braket lists five hardware providers (AWS, accessed October 2026), and Azure Quantum lists four (Microsoft Learn, updated April 2026). A buyer can run a first test inside a cloud account its IT team already approved, and pay from cloud budget it has already committed.
Prices are public, which helps you set the size of a study. Braket charges $0.30 per task plus a per-shot fee, and a reserved hour through Braket Direct costs $4,100 on one superconducting device and $7,000 on one trapped-ion device (AWS, accessed October 2026). Quote compute as a pass-through line in your study price, so the sponsor sees what your team's work costs.
Software and algorithm companies should stay hardware neutral and run on whatever the buyer's cloud offers. Hardware companies should treat a listing as a way to remove vendor onboarding, and keep direct outreach to the R&D owner.
How do government and consortium programmes open doors?
They give a small company third-party validation, funding, and a reason for an enterprise R&D head to take the call. DARPA's Quantum Benchmarking Initiative pays up to $1 million in Stage A, up to $15 million in Stage B and up to $300 million in Stage C, and has evaluated more than 20 organisations since mid-2024 (DARPA, accessed October 2026). Wellcome Leap's Q4Bio funds up to $40 million of research plus up to $10 million in prizes for quantum applications in human health (accessed October 2026).
Use these programmes as introductions. A grant-funded project with a pharma or chemicals partner becomes your first reference. Industry consortia and national quantum centres run challenges where corporate members state their problems in public, which tells you who owns the budget before you write to them.
Who signs the first contract?
Three people usually touch the first contract: a champion, a budget owner and a signer. In R&D, a quantum or computational science lead champions the study, the head of R&D or innovation owns the budget, and procurement signs above its threshold. In security, the CISO or head of security architecture owns the migration, and the CIO, risk committee and third-party risk team approve the vendor. The NCSC addresses its guidance to "technical decision-makers and risk owners", which tells you who to brief.
| Buyer | Use case | Typical first deal shape |
|---|---|---|
| Pharma R&D, computational chemistry | Molecular simulation, binding energy | Fixed-fee exploration study with a classical baseline, run on cloud hardware |
| Chemicals and materials R&D | Catalyst and battery materials simulation | Fixed-fee study, often co-funded by a grant or consortium |
| Bank quant or innovation team | Portfolio optimisation, risk simulation, pricing | Paid proof of concept benchmarked against current models |
| Logistics or manufacturing operations research | Routing, scheduling, network design | Optimisation pilot with a quantum-inspired fallback |
| CISO and security architecture | Cryptographic inventory, PQC migration | Discovery project, then an annual licence or subscription |
| Government agency or national lab | Benchmarking, testbeds, sovereign capability | Staged grant or contract with milestone payments |
Map the champion, the budget owner and the signer for every account on your list before outreach starts. If you want meetings with these buyers booked for you, our free trial books your first 3 qualified meetings at no cost, and Outbound runs at $5K a month plus a fee per meeting held.
To find which of these buyers your team can reach this quarter, start with The Diagnostic.